Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial

This publication has 16 references indexed in Scilit:

• Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
  Radiology, 1996
• Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients
  The Lancet, 1995
• Total androgen blockade with the use of orchiectomy and nilutamide (anandron) or placebo as treatment of metastatic prostate cancer
  Cancer, 1993
• Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)
  Urology, 1993
• Carcinoma of the Prostate
  New England Journal of Medicine, 1991
• A Phase III Trial of Zoladex and Flutamide Versus Orchiectomy in the Treatment of Patients With Advanced Carcinoma of the Prostate
  Cancer, 1990
• Zoladex with or without Flutamide in the Treatment of Locally Advanced or Metastatic Prostate Cancer: Interim Analysis of an Ongoing PONCAP Study
  European Urology, 1990
• Orchidectomy vs. Zoladex plus Flutamide in Patients with Metastatic Prostate Cancer
  European Urology, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• Flutamide as Primary Treatment for Metastatic Prostatic Cancer
  British Journal of Urology, 1987